Table 5.
Treatment received in Colombian adolescent and adult atopic dermatitis patients
| Variable | n = 212 | <18 years old n = 47 | >18 years old n = 165 |
|---|---|---|---|
| Topical treatments, n (%) | |||
| Moisturizers | 209 (98.6) | 47 (100) | 162 (98.2) |
| Topical corticosteroids | 206 (97.2) | 46 (97.9) | 160 (96.7) |
| Topical tacrolimus | 126 (59.4) | 20 (42.5) | 106 (64.2) |
| Systemic treatments, n (%) | |||
| Oral antihistamines | 183 (86.3) | 41 (87.2) | 142 (86) |
| Systemic steroids | 133 (62.7) | 23 (48.9) | 110 (66.6) |
| Phototherapy | 131 (61.8) | 28 (59.5) | 103 (62.4) |
| Azathioprine | 60 (28.3) | 7 (14.9) | 53 (32.1) |
| Cyclosporine | 47 (22.2) | 6 (12.7) | 41 (25) |
| Methotrexate | 36 (17.0) | 8 (17) | 28 (17) |
| Mycophenolate mofetil | 8 (3.8) | 2 (4.2) | 6 (3.6) |
| Biologic therapy, n (%) | |||
| Dupilumab | 14 (6.6) | 0 (0.0) | 14 (8.5) |
| Omalizumab | 12 (5.7) | 3 (6.3) | 9 (5.5) |